Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
5.13 USD | +1.58% | -6.39% | +21.56% |
08/05 | Transcript : Vanda Pharmaceuticals Inc., Q1 2024 Earnings Call, May 08, 2024 | |
08/05 | Earnings Flash (VNDA) VANDA PHARMACEUTICALS Reports Q1 Revenue $47.5M | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+21.56% | 30Cr | |
+5.33% | 11TCr | |
+12.11% | 11TCr | |
-12.56% | 2.22TCr | |
-3.44% | 2.13TCr | |
-5.80% | 1.9TCr | |
-35.21% | 1.85TCr | |
-10.86% | 1.68TCr | |
+37.57% | 1.25TCr | |
-26.24% | 808.97Cr |
- Stock Market
- Equities
- VNDA Stock
- News Vanda Pharmaceuticals Inc.
- Vanda Pharmaceuticals Plans to File Petition With US Supreme Court in Hetlioz Abbreviated NDA Lawsuit